ID
44441
Description
Study part: Administrative Data. A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Keywords
Versions (2)
- 6/10/18 6/10/18 -
- 9/20/21 9/20/21 -
Copyright Holder
GlaxoSmithKline
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Administrative Data Pazopanib Macular Degeneration MD1103367
Administrative Data
- StudyEvent: ODM
Description
INFORM ENROLMENT (ENROL)
Alias
- UMLS CUI-1
- C2348568
Description
DATE OF VISIT (DoV)
Alias
- UMLS CUI-1
- C1320303
Description
DEMOGRAPHY (Demog)
Alias
- UMLS CUI-1
- C0011298
Description
Sex
Data type
text
Alias
- UMLS CUI [1]
- C0079399
Description
Female of child bearing age
Data type
integer
Alias
- UMLS CUI [1]
- C1960468
Description
Ethnicity
Data type
integer
Alias
- UMLS CUI [1]
- C0015031
Description
Race
Data type
integer
Alias
- UMLS CUI [1]
- C0034510
Similar models
Administrative Data
- StudyEvent: ODM
C2986440 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0152035 (UMLS CUI-2)
C1556095 (UMLS CUI-3)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)